+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
S

Actively Recruiting

Researchers are investigating the safety and effectiveness of Phentolamine Ophthalmic Solution POS in adults who have previously undergone keratorefractive surgery and now experience decreased vision under low light, or mesopic, conditions. This Phase 3 trial compares POS to a placebo to determine if POS can improve night vision in this group. Participants will be randomly assigned to receive either 0.75% Phentolamine Ophthalmic Solution or a placebo eye drop once daily for two weeks. Weekly clinic visits during this period will include checkups and tests. Participants will also maintain a diary to record their daily medication use each evening. Throughout the study, participants will undergo various vision tests and questionnaires to measure changes in visual acuity under mesopic conditions and effects on night driving difficulties. Safety and vision improvements will be closely monitored during the two-week treatment and at follow-up visits. The trial is expected to last until August 2027.

Age: 18Years +All GendersPhase 3
20 locations
G

Actively Recruiting

The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program SDS-GPS provides a secure online platform for patients and families worldwide to share their experiences living with Shwachman-Diamond Syndrome SDS and related conditions. The program aims to deepen understanding of SDS, enhance patient lives, and speed up the development of new therapies and cures by gathering patient-reported data. SDS-GPS was created with input from patients, families, advocates, researchers, and clinicians to build a supportive global community that drives research forward. Participants create a free account to enter their information and complete surveys covering topics such as demographics, medical history, treatments, disease progression, care access, and quality of life. These surveys can be completed anytime from home and saved for later. The platform supports multiple languages and allows participants to track their medical appointments, medications, and symptoms. The program collects de-identified data to prioritize research, share knowledge, and connect participants with relevant clinical trials and registries. Throughout the program, participants provide ongoing information about symptoms, genetics, quality of life, and disease burden at baseline and at regular intervals such as every 12 months or multiple times per year. This long-term observational approach helps researchers understand patient needs and outcomes. Participation involves no clinic visits or virtual appointments, and privacy and security are maintained at the highest standards. The program offers early access to new research opportunities and supports participants in sharing information with their care teams as they choose.

All AgesAll Genders
1 location